Get the Stockscreener App
301.50
0.65%
1.96
After Hours:
303.97
2.47
+0.82%
Bio Rad Laboratories Inc stock is traded at $301.50, with a volume of 201.72K.
It is up +0.65% in the last 24 hours and down -7.37% over the past month.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
See More
Previous Close:
$299.54
Open:
$301.66
24h Volume:
201.72K
Relative Volume:
1.07
Market Cap:
$8.13B
Revenue:
$2.58B
Net Income/Loss:
$-778.69M
P/E Ratio:
-11.03
EPS:
-27.33
Net Cash Flow:
$223.75M
1W Performance:
+2.66%
1M Performance:
-7.37%
6M Performance:
+14.07%
1Y Performance:
-12.71%
1-Day Range:
$298.35
$307.39
1-Week Range:
$289.11
$313.41
52-Week Range:
$211.43
$345.70
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Name
Bio Rad Laboratories Inc
Sector
Industry
Phone
(510) 724-7000
Address
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
301.50 | 8.08B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
110.83 | 189.68B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
358.29 | 138.60B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
102.90 | 131.98B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
76.27 | 115.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.71 | 45.32B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-03-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-07-23 | Initiated | UBS | Buy |
| Jun-16-23 | Initiated | Wells Fargo | Overweight |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jan-28-22 | Reiterated | Citigroup | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-17-18 | Initiated | Goldman | Buy |
| Sep-20-18 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-16-18 | Downgrade | CL King | Buy → Neutral |
| Jul-13-17 | Initiated | Wells Fargo | Outperform |
| Jun-28-17 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-18-17 | Initiated | Deutsche Bank | Hold |
| Oct-13-16 | Initiated | CL King | Buy |
| May-06-15 | Reiterated | Jefferies | Buy |
| Dec-18-09 | Initiated | Maxim Group | Buy |
| Nov-06-09 | Initiated | Jefferies & Co | Buy |
| Jul-17-09 | Initiated | Soleil | Buy |
| Sep-26-07 | Initiated | Banc of America Sec | Buy |
| Feb-23-07 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Bio Rad Laboratories Inc Stock (BIO) Latest News
Bio-Rad EZ-Check Listeria Test Kits Receive AOAC Validation - Food Safety Magazine
Multiplex Immunoassays Market to Reach US$ 6.90 Billion by 2033 - openPR.com
The Latest in ddPCR Technology - the-scientist.com
Polymerase Chain Reaction Market Set for Rapid Growth and Trend - openPR.com
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap DownWhat's Next? - MarketBeat
United States Digital PCR Market to Reach at 7.4% CAGR by 2031; - openPR.com
DNA Sequencing Market Covering Prime Factors and Competitive - openPR.com
Mawer Investment Management Ltd. Reduces Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Veritas Asset Management LLP Has $236.66 Million Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Chromatography Research Report 2026 - GlobeNewswire Inc.
Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026 - BioSpace
Universal Beteiligungs und Servicegesellschaft mbH Has $3.63 Million Stock Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
North America Gas Chromatography Market Forecast Report - GlobeNewswire
North America Gas Chromatography Market Forecast Report 2025-2033 Featuring Agilent, Bio-Rad, Chromatotec, Merck, PerkinElmer, Phenomenex, Restek, Shimadzu, Thermo Fisher Scientific, Waters - Yahoo Finance Singapore
What Bio-Rad Laboratories (BIO)'s AI-Driven Protein Assay Upgrades Mean For Shareholders - Sahm
United States Electroporation Instruments and Consumables - openPR.com
Shigella Test Kit Market 2026 Is Booming Worldwide by 2033 - openPR.com
Difficult-to-Express Proteins Market to Reach USD 9.05B by 2031 - openPR.com
Bank Watch: Is Bio Rad Laboratories Incs ROE strong enoughStock Surge & Weekly Top Gainers Trade List - baoquankhu1.vn
Incredible Growth of Cancer Monoclonal Antibodies Market - openPR.com
Cell Culture Media Market Covering Prime Factors - openPR.com
Biomarkers Market to Reach US$ 148.88B by 2032 | CAGR 11.9% | North - openPR.com
Microarrays Market Size to Accumulate Around USD 10.72 Billion by 2033, Driven by Expanding Genomics Research and Advanced Diagnostic Adoption – SNS Insider - GlobeNewswire Inc.
Income Plays: Is XFLTPRA a good ESG investmentWeekly Trade Review & Daily Entry Point Trade Alerts - baoquankhu1.vn
Sector Gamma AS Buys 4,998 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Rating of "Hold" from Analysts - MarketBeat
Assessing Bio-Rad Laboratories (BIO) Valuation After Prolonged Share Price Weakness - Yahoo Finance
Performance Recap: Can Bio Rad Laboratories Inc generate free cash flowWeekly Market Summary & Free High Return Stock Watch Alerts - baoquankhu1.vn
Rapid Food Safety Testing Growth Driven by SGS Leadership - Market.us
Thermal Cycler Market Market Set to Boom: Strategic Insights - openPR.com
Is Bio-Rad Laboratories (BIO) Starting To Look Attractive After Prolonged Share Price Weakness? - Sahm
Bio-Rad Laboratories Still Hampered By Underwhelming Core Growth - Seeking Alpha
Cell Counting System Market Overview and Leading Players: - openPR.com
Bio-Rad Laboratories (NYSE:BIO.B) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Proteomics Market Dynamics and Contributions by Thermo Fisher - openPR.com
Qiagen Explores Possible Sale After New Buyer Talks: Report - Sahm
Here's Why You Should Hold Bio-Rad Stock in Your Portfolio Now - TradingView
Forensic Technology Market Is Going to Boom | Agilent Technologies • QIAGEN • Bio-Rad Laboratories • LGC Limited - openPR.com
United States Protein Labeling Market Growth (2025-2032): Key - openPR.com
Lab on Chip Market Set for Dynamic Development with Key Players - openPR.com
Nucleotide Market Is Going to Boom | Agilent Technologies • Bio-Rad Laboratories • QIAGEN - openPR.com
AI Stocks: Is Bio Rad Laboratories Inc likely to announce a buybackNew Guidance & Long-Term Investment Growth Plans - baoquankhu1.vn
Trading Action: Can Bio Rad Laboratories Inc generate free cash flowJuly 2025 Closing Moves & Advanced Technical Signal Analysis - baoquankhu1.vn
Bio-Rad Laboratories Is Quietly Eating the Lab World – But Is BIO Stock Worth Your Cash? - AD HOC NEWS
Protein Chip Market to Reach US$ 7.6 Billion by 2032 at 15.9% CAGR; - openPR.com
Blood Screening Market Outlook 2026-2033: Technological - openPR.com
Microfluidics Market to Reach US$ 73.97 Billion by 2032 at 12.6% - openPR.com
Revenue Check: How correlated is Bio Rad Laboratories Inc to the S P5002025 Macro Impact & Verified Trade Idea Suggestions - baoquankhu1.vn
DNA/RNA Extraction Kit Market to Reach US$ 6.9 Billion by 2032 - openPR.com
SG Americas Securities LLC Buys 5,600 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Fund Flows: Can RF Acquisition Corp II Debt Equity Composite Units ride the EV waveMarket Trend Report & Expert Verified Movement Alerts - baoquankhu1.vn
Bio Rad Laboratories Inc Stock (BIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.33%
2.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):